Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine · 2000
[Effect of Composite Salviae Dropping Pill on function of platelet activation in patients with unstable angina pectoris].
Клиническое исследованиеАннотация на английскомСтатьяРандомизированное исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Jin L
Аннотация
OBJECTIVE: To explore the effect of Composite Salviae Dropping Pill (CSDP) on the level of alpha-granule membrane protein-140 (GMP-140) in unstable angina pectoris (UAP).
METHODS: Forty-two patients of UAP were randomly divided into the CSDP group and the control group, 21 cases in each group. The two groups were all received the treatment of aspirin and other conservative agents, and CSDP was given to the CSDP group orally, 10 pills three times a day for 4 weeks additionally. The GMP-140 level was determined by ELISA, changes of symptoms of angina, ECG were observed before and after treatment. Besides, 22 healthy persons were selected as the normal control.
RESULTS: The level of GMP-140 in the two treated groups was significantly higher than that in the normal control group before treatment (P < 0.01). After 4 weeks' treatment of CSDP, the symptoms of angina, ischemia feature in ECG improved in the CSDP group more apparently than those in the control group. Moreover, the GMP-140 level in the CSDP group was reduced significantly as compared with the control group, and to approach the level of normal (P > 0.05), while in the control group, it was higher as compared with the normal control (P < 0.05).
CONCLUSION: CSDP combined with aspirin may inhibit platelet activation in UAP patients and showed good effect in ameliorating angina in clinical practice.
METHODS: Forty-two patients of UAP were randomly divided into the CSDP group and the control group, 21 cases in each group. The two groups were all received the treatment of aspirin and other conservative agents, and CSDP was given to the CSDP group orally, 10 pills three times a day for 4 weeks additionally. The GMP-140 level was determined by ELISA, changes of symptoms of angina, ECG were observed before and after treatment. Besides, 22 healthy persons were selected as the normal control.
RESULTS: The level of GMP-140 in the two treated groups was significantly higher than that in the normal control group before treatment (P < 0.01). After 4 weeks' treatment of CSDP, the symptoms of angina, ischemia feature in ECG improved in the CSDP group more apparently than those in the control group. Moreover, the GMP-140 level in the CSDP group was reduced significantly as compared with the control group, and to approach the level of normal (P > 0.05), while in the control group, it was higher as compared with the normal control (P < 0.05).
CONCLUSION: CSDP combined with aspirin may inhibit platelet activation in UAP patients and showed good effect in ameliorating angina in clinical practice.